NEFL and Parkinson disease: In the study by Uyar et al. with 195 subjects, T2DM in PD patients was associated with higher serum neurofilament light chain levels in the linear regression model after adjustment for age and BMI, serving as a marker for more profound neuronal damage in these patients (Uyar et al. 2022).